In the great majority of CML patients (~95%), the break in BCR occurs within the region between exons 12 and 16 (e12-e16, historically named b1-b5), called the major-breakpoint cluster region (M-BCR). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.